|
Category: buffering agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | white crystalline solid (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Boiling Point: | 355.50 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000005 mmHg @ 25.00 °C. (est) |
| Flash Point: | 361.00 °F. TCC ( 183.00 °C. ) (est)
|
| logP (o/w): | -0.008 (est) |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-human TDLo 215 mg/kg GASTROINTESTINAL: OTHER CHANGES
GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
GASTROINTESTINAL: NAUSEA OR VOMITING Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 1, 1942.
oral-mouse LD10 3680 mg/kg Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 12, 1942.
intravenous-rabbit LDLo 500 mg/kg LUNGS, THORAX, OR RESPIRATION: ACUTE PULMONARY EDEMA
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 31, Pg. 1, 1942.
oral-rat LD50 8000 mg/kg "Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia, Avicenum, 1986Vol. -, Pg. 314, 1986.
intraperitoneal-rat LDLo 2420 mg/kg BLOOD: HEMORRHAGE
BEHAVIORAL: IRRITABILITY Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 35, Pg. 298, 1946.
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | buffering agents |
| Recommendation for disodium fumarate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for disodium fumarate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
| European Food Safety Authority (EFSA) reference(s): |
Review of substances/agents that have direct beneficial effect on the environment: mode of action and assessment of efficacy View page or View pdf |
| EPI System: | View |
| AIDS Citations: | Search |
| Cancer Citations: | Search |
| Toxicology Citations: | Search |
| EPA ACToR: | Toxicology Data |
| EPA Substance Registry Services (SRS): | Registry |
| Laboratory Chemical Safety Summary : | 6364607 |
| National Institute of Allergy and Infectious Diseases: | Data |
| WGK Germany: | 2 |
| | disodium;(E)-but-2-enedioate |
| Chemidplus: | 0017013013 |
| RTECS: | LT1830000 for cas# 17013-01-3 |
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 2- | butenedioic acid (E)-, disodium salt | | (E)-2- | butenedioic acid disodium salt | | 2- | butenedioic acid, disodium salt, (2E)- (1:2) | | | disodium (2E)-but-2-enedioate | | | disodium;(E)-but-2-enedioate | | | fumaric acid disodium salt | | | fumaric acid, disodium salt |
Articles:
|